跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOTIMIR 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DOTIMIR 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Approved
STANDARD
DOTIMIR 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Omnivision Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 20, 2025
Approval ID
1a474b8a30dcfc8b
Company
Omnivision Gmbh
Type
Standard
Approval Details
Approval Id
1a474b8a30dcfc8b
Drug Cima Aemps Name
DOTIMIR 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Register Number
90079
Holder Company Name
Omnivision Gmbh
Marketing Company Name
Omnivision Gmbh
Holder Company Detail Path
/organization/omnivision-gmbh
Marketing Company Detail Path
/organization/omnivision-gmbh
Authorization Date
2025-01-20
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
20 MG/ML+5 MG/ML
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Omnivision Gmbh
Company Detail Path
/organization/omnivision-gmbh
Company Information
Pharmaceutical Company Name
OmniVision GmbH
Country Name
Austria
City Name
wien,wien,country_at
Address
Anton Anderer-Platz 6/1
Active Ingredients
DORZOLAMIDA HIDROCLORURO
22,26 mg/ml
TIMOLOL MALEATO
6,83 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 20, 2025
Approval ID
1a474b8a30dcfc8b
Type
Standard
Back to CIMA-AEMPS Approvals
